Larvol Delta - Century-Therapeutics-Announces-InvestigatorInitiated-Phase-12-Trial-of-its-iPSCderived-iNK-Cell-Therapy-CNTY101-in-Bcell-Mediated-Autoimmune-Diseases-Sponsored-by-Internationally-Renowned-Key-Opinion-Leaders

CNTY-101 - Century Therap

https://www.globenewswire.com/news-release/2025/01/21/3012514/0/en/Century-Therapeutics-Announces-Investigator-Initiated-Phase-1-2-Trial-of-its-iPSC-derived-iNK-Cell-Therapy-CNTY-101-in-B-cell-Mediated-Autoimmune-Diseases-Sponsored-by-Internationa.html

Jan 21, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next